We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
CONTEXT In the last decade, several epidemiological studies have shown the increased risk of venous thromboembolism associated with third- and fourth-generation oral contraceptives (C3Gs and C4Gs) versus older combined first- and second-generation oral contraceptives (C1Gs and C2Gs). In France, in December 2012, a lawsuit filed against the National Agency(More)
  • 1